comparemela.com

Latest Breaking News On - Cardiac arrhythmia institute - Page 3 : comparemela.com

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation

BioSig Technologies Inc increases patient case goal from 1,000 to at least 1,500 procedures by end of 2021

BioSig Technologies increases patient case goal to 1,500 procedures by end of 2021 The company previously announced its target to complete 1,000 patient cases in 2021, having delivered 425 procedures by the end of 2020 BioSig’s non-invasive computerized technology, the PURE EP System, aims to drive procedural efficiency and efficacy in electrophysiology BioSig Technologies Inc (NASDAQ:BSGM), which is commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, has increased its patient case goal to at least 1,500 procedures by the end of 2021. BioSig’s non-invasive computerized technology, the PURE EP System, aims to drive procedural efficiency and efficacy in electrophysiology. The system provides essential diagnostic signals with high clinical value in all cardiac ablations that treat irregular heartbeats or arrhythmias.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.